Black Cumin for Blood Pressure: Evidence and Dosage from Research
This conversation examines whether black cumin (Nigella sativa) helps lower blood pressure, citing two studies from Pillser's database. It discusses mixed evidence, including a 2024 RCT using 1000 mg/day with neutral results, and advises consulting a healthcare professional before use.
Does black cumin really help lower blood pressure, and how much would someone need to take to see a benefit?
Based on Pillser's research database, here's what we know about black cumin (Nigella sativa) and blood pressure:
Evidence Overview
Pillser has catalogued 2 studies examining black cumin's effect on blood pressure:
- 1 study showed a beneficial effect (from a 2023 systematic review and meta-analysis overview suggesting N. sativa is beneficial for various clinical outcomes, including blood pressure)1
- 1 study showed a neutral effect — a 2024 randomized controlled trial in adolescents with PCOS using 1000 mg/day found no statistically significant changes in blood pressure2
Dosage Used in Research
The one RCT that specifically measured blood pressure used 1000 mg per day of Nigella sativa, but did not find a significant effect. The broader systematic review that indicated benefit didn't specify a single dose, as it aggregated multiple studies.
Bottom Line
The evidence is mixed and limited. While some aggregate data from systematic reviews suggests black cumin may have a small beneficial effect on blood pressure, the most recent individual trial (2024) using 1000 mg/day did not find a significant reduction. This is not enough evidence to confidently recommend a specific dose for blood pressure management.
Important: If you have high blood pressure, please consult a healthcare professional. Supplements should not replace prescribed medications or lifestyle modifications (diet, exercise, sodium reduction) that are well-established for managing hypertension.
Footnotes
-
Pillser research database, Black Cumin and Reduced Blood Pressure. ↩
-
"The possible short-term of Nigella sativa - L in the management of adolescent polycystic ovarian syndrome: results of a randomized controlled trial" (2024), Pillser. ↩